Johns Hopkins University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count).
Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.
Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.
Top-decile sponsor footprint
Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,448 total, page 7 of 29
The Use of Technology to Improve MS Clinical Trials and Patient Care
NCT02454907
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
NCT03500328
Pilot Study of an mHealth Intervention for Living Donor Follow-up
NCT03400085
Fetoscopic Repair of Isolated Fetal Spina Bifida
NCT03090633
Men and Women Offering Understanding of Throat HPV
NCT03644563
Expanding Live Donor Kidney Transplantation Through Advocacy Training and Social Media
NCT03099434
Use of Financial Incentives to Increase Live Kidney Donor Follow-up Compliance
NCT03090646
AIRWEIGHS: Investigating Obesity as a Susceptibility Factor for Air Pollution in Childhood Asthma
NCT02763917
Multichannel Vestibular Implant Early Feasibility Study
NCT02725463
Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy
NCT02694094
Fetoscopic Endoluminal Tracheal Occlusion (FETO) for Severe Left Diaphragmatic Hernia (CDH)
NCT02710968
The Very Large Database of Lipids
NCT01698489
Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS)
NCT01169194
Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus
NCT00431756
Johns Hopkins Crohn's Disease and Ulcerative Colitis Study
NCT01169207
Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety
NCT06236542
ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing
NCT03767231
Enhancing Wound Perfusion in High-Risk Lower Extremity Orthopaedic Surgery: A Study on Nitropaste Using Intraoperative SPY Imaging.
NCT07004764
Impact of Exogenous Ketones on Sleep Apnea
NCT06687655
Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)
NCT07665372
Examining the Role of Tolerance on Dose-dependent Effects of Acute THC on Oculomotor and Cognitive Performance
NCT06351540
Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving
NCT07148843
Use of N-Acetylcysteine in the Treatment of Repetitive and Self-Injurious Behaviors in Cornelia de Lange Syndrome
NCT04381897
The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens
NCT02998502
Deep Brain Stimulation for Treatment-Resistant Schizophrenia
NCT07592611
Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain
NCT07264920
Peer Support for Liver Transplant Recipients With History of ALD
NCT07397598
Shortened LSD Intervention for Major Depressive Disorder
NCT07503002
Voice Quality Analysis of Patients With Laryngotracheal Stenosis
NCT06161077
Risk-informed Shared-decision Making Engagement Strategy for Patients With Prediabetes
NCT07553325
The INTERvening for LUNG Health Trial
NCT07540000
Psilocybin Efficacy With or Without Pimavanserin Pretreatment
NCT07610135
Combination Therapy for Alcohol Use Disorder
NCT07249554
Behavioral Pharmacology of THC and Beta-Myrcene
NCT05432284
Oral N-acetylglucosamine in Crohn's Disease
NCT07225998
Emetine for Viral Outbreaks (a.k.a. EVOLVE Antiviral Initiative)
NCT07016321
Multimodal Glucose Prediction in Type 2 Diabetes
NCT07633171
Personalized Closed-Loop Brain Stimulation for Patients With Primary Progressive Aphasia
NCT07511179
Personalized Closed-Loop Brain Stimulation for Patients With Mild Cognitive Impairment
NCT07512193
The Pharmacokinetics of a Hemp-Based Topical Product
NCT07603518
Delivering a Digital Health Intervention to Improve Food Access and Dietary Quality Among Adults With Hypertension
NCT06743191
Study of Produce Prescription Programs in Adults With Overweight or Obesity Experiencing Nutrition Insecurity
NCT06751563
C-Raven, a Virtual Tobacco Cessation Intervention in the Community
NCT06545669
Chocolate or Sevoflurane: Use of Parosmia to Facilitate More Cooperative Inhalation Inductions in Children
NCT06449157
Use Of Gigstride Device In Patients With Lower Extremity Deficit
NCT06548087
Randomizing Vignettes to Understand Contributors to Trust in Primary Care Doctors
NCT06526663
Safety and Feasibility of Hyperkalemic Cardioplegia With Diazoxide in Cardiac Surgery (CPG-DZX) Trial
NCT06308107
Delta-8-THC vs. Delta-9-THC on Simulated Driving Performance
NCT06218550
Differences in Corneal Structure and Function in Patients With Sjogrens vs. Non-Sjogrens Dry Eye
NCT06364657
AdapTive Personalized Dietitian coacHing, Messaging and pRoduce prescrIption to improVE Healthy Dietary Behaviors
NCT06257550
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 201 |
| Phase 2 | 198 |
| Phase 3 | 44 |
| Phase 4 | 81 |
Therapeutic Areas
What is open in the Johns Hopkins University pipeline
250 recruiting of 1,448 indexed (17% open); 943 completed (65%).
Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).
Top condition: Hypertension (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.